.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Viewpoints on Pancreatic Ductal Adenocarcinoma

EP. 1: Biological Breakthroughs in Pancreas Cancer

October 10th 2017

EP. 2: Precision Medicine for Pancreatic Cancer

October 10th 2017

EP. 3: Sequential Therapy for Metastatic Pancreas Cancer

October 10th 2017

EP. 4: Modifying Chemotherapy Regimens in Pancreas Cancer

October 10th 2017

EP. 5: Palliative Care Recommendations in Pancreas Cancer

October 10th 2017

EP. 6: Pancreas Cancer: Incorporating Nanoliposomal Irinotecan

October 10th 2017

EP. 7: Adjuvant Therapy Recommendations in Pancreas Cancer

October 10th 2017

EP. 8: Role of Adjuvant Radiation Therapy in Pancreas Cancer

October 10th 2017

EP. 9: Neoadjuvant Therapy Recommendations in Pancreas Cancer

October 10th 2017

EP. 10: Management of Borderline Resectable Pancreas Cancer

October 10th 2017

EP. 11: Clinical Research in the Treatment of Pancreas Cancer

October 10th 2017

EP. 12: Pancreas Cancer: Investigational Targeted Approaches

October 10th 2017

EP. 13: Pancreas Cancer Treatment Forecast

October 10th 2017

EP. 14: PEGPH20: A Novel Agent for Pancreatic Adenocarcinoma

October 10th 2017

EP. 15: PEGPH20: Future Directions in Pancreatic Adenocarcinoma

October 10th 2017